Summit Therapeutics Inc vs TKO Group Holdings Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while TKO Group Holdings Inc trades at $181.83 (market cap $13.70B). The key difference: TKO Group Holdings Inc is the larger of the two by market cap, and TKO Group Holdings Inc pays a 1.7% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | TKO | |
|---|---|---|
Market Cap | $10.48B | $13.70B |
Sector | Health | Technology |
52-Week High | $29.32 | $224.96 |
52-Week Low | $13.05 | $155.61 |
Enterprise Value | $9.90B | $17.88B |
Dividend Yield | — | 1.7% |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →